MetLife Inc. (NYSE:MET) was downgraded by FBR & Co from an “outperform” rating to a “market perform” rating in a report issued on Monday. They presently have a $54.00 target price on the stock. FBR & Co’s price target points to a potential downside of 0.35% from the stock’s previous close. The analysts noted that the move was a valuation call.

A number of other research analysts also recently issued reports on the company. Argus restated a “buy” rating and set a $54.00 price target on shares of MetLife in a report on Tuesday, November 8th. JPMorgan Chase & Co. restated a “buy” rating and set a $51.00 price target on shares of MetLife in a report on Friday, November 4th. TheStreet upgraded MetLife from a “hold” rating to a “buy” rating in a report on Friday, October 28th. Zacks Investment Research downgraded MetLife from a “hold” rating to a “sell” rating in a report on Wednesday, October 26th. Finally, Deutsche Bank AG restated a “hold” rating and set a $44.00 price target on shares of MetLife in a report on Saturday, October 8th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, eleven have given a buy rating and two have issued a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $51.35.

Analyst Recommendations for MetLife (NYSE:MET)

Shares of MetLife (NYSE:MET) opened at 54.19 on Monday. MetLife has a 12-month low of $35.00 and a 12-month high of $55.49. The firm has a market capitalization of $59.56 billion, a P/E ratio of 16.65 and a beta of 1.66. The company has a 50-day moving average price of $49.69 and a 200-day moving average price of $44.47.

MetLife (NYSE:MET) last announced its quarterly earnings results on Wednesday, November 2nd. The company reported $1.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.04. MetLife had a return on equity of 6.99% and a net margin of 5.58%. The company had revenue of $17.70 billion for the quarter, compared to the consensus estimate of $17.03 billion. During the same quarter in the previous year, the business earned $0.62 EPS. MetLife’s revenue was down 99.9% compared to the same quarter last year. Equities analysts predict that MetLife will post $4.63 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 13th. Investors of record on Monday, November 7th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Thursday, November 3rd. This represents a $1.60 dividend on an annualized basis and a yield of 2.95%. MetLife’s payout ratio is currently 49.23%.

ILLEGAL ACTIVITY WARNING: “MetLife Inc. (MET) Rating Lowered to Market Perform at FBR & Co” was reported by Financial Market News and is the sole property of of Financial Market News. If you are accessing this piece on another site, it was stolen and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be viewed at http://www.financial-market-news.com/metlife-inc-met-rating-lowered-to-market-perform-at-fbr-co/1210015/.

In related news, EVP Frans Hijkoop sold 56,250 shares of the business’s stock in a transaction that occurred on Wednesday, November 9th. The shares were sold at an average price of $51.48, for a total value of $2,895,750.00. Following the completion of the transaction, the executive vice president now directly owns 111,813 shares in the company, valued at approximately $5,756,133.24. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Maria R. Morris sold 2,200 shares of the business’s stock in a transaction on Tuesday, November 1st. The shares were sold at an average price of $47.33, for a total transaction of $104,126.00. Following the sale, the executive vice president now owns 109,809 shares of the company’s stock, valued at $5,197,259.97. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by corporate insiders.

A number of large investors have recently made changes to their positions in the stock. Jacobus Wealth Management Inc. bought a new stake in shares of MetLife during the third quarter worth $104,000. Carroll Financial Associates Inc. raised its stake in shares of MetLife by 51.5% in the third quarter. Carroll Financial Associates Inc. now owns 2,625 shares of the company’s stock worth $116,000 after buying an additional 892 shares in the last quarter. Woodmont Investment Counsel LLC bought a new stake in shares of MetLife during the third quarter worth $120,000. Livingston Group Asset Management CO operating as Southport Capital Management bought a new stake in shares of MetLife during the second quarter worth $110,000. Finally, ClariVest Asset Management LLC raised its stake in shares of MetLife by 0.3% in the second quarter. ClariVest Asset Management LLC now owns 2,806 shares of the company’s stock worth $112,000 after buying an additional 8 shares in the last quarter. Institutional investors and hedge funds own 74.19% of the company’s stock.

MetLife Company Profile

MetLife, Inc (MetLife) is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA).

5 Day Chart for NYSE:MET

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.